Haemonetics HAE Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's pre-tax income?
- Haemonetics (HAE) reported pre-tax income of $59.98M in Q4 2025.
- How has Haemonetics's pre-tax income changed year-over-year?
- Haemonetics's pre-tax income increased by 20.1% year-over-year, from $49.92M to $59.98M.
- What is the long-term trend for Haemonetics's pre-tax income?
- Over 3 years (2022 to 2025), Haemonetics's pre-tax income has grown at a 49.4% compound annual growth rate (CAGR), from $63.63M to $212.07M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.